Adriane Hommertgen
Papers
1
Total Citations
11
H-Index
1
About
Adriane Hommertgen is a clinical researcher whose work focuses on advancing stereotactic radiosurgery (SRS) for brain metastases, particularly through improved imaging and treatment precision. Her most cited study, the CYBER-SPACE trial (2018, 11 citations), is a landmark single-center prospective randomized investigation comparing two MRI sequences—SPACE and MPRAGE—for diagnosing brain metastases prior to robotic radiosurgery. This work directly addresses the critical need for accurate lesion detection in patients with multiple brain metastases, a population increasingly considered for SRS over whole-brain radiotherapy due to its lower toxicity. By evaluating how different imaging modalities influence treatment planning and outcomes, Hommertgen has contributed to refining clinical protocols that enhance the efficacy and safety of radiosurgery. Her research sits at the intersection of neuroradiology and radiation oncology, offering practical insights for optimizing patient selection and target delineation. Though early in her career, her work has already informed best practices for managing oligometastatic disease, demonstrating a commitment to evidence-based improvements in cancer care. Hommertgen’s findings remain relevant for clinicians seeking to balance tumor control with quality of life in brain metastasis patients.
Research Focus
Key Achievements
Top Papers
- 1